Senseonics Holdings, Inc., a medical technology company specializing in implantable continuous glucose monitoring systems, will announce its first quarter 2026 financial results after market close on May 7, 2026. The company will also host a conference call at 4:30 p.m. Eastern Time the same day to discuss its performance. Investors can access the webcast via Senseonics' website. This update follows the company's recent $80 million public offering of common stock and pre-funded warrants, signaling ongoing growth and investor interest.
The global coffee substitute market, valued at $15.5 billion in 2025, is projected to grow at a 4.8% CAGR to reach $24.3 billion by 2035. Growth is fueled by rising consumer awareness of caffeine-related health issues and a shift towards clean-label,...
The global connected vehicle technology market, valued at $45.3 billion in 2025, is projected to grow at a CAGR of 11.4% to reach $129.2 billion by 2035. Growth is driven by the adoption of advanced driver assistance systems (ADAS), 5G connectivity e...
The global fish sauce market, valued at $3.1 billion in 2025, is projected to grow at a 5.3% CAGR to reach $5.1 billion by 2035. Growth is driven by the increasing global popularity of Southeast Asian cuisines and rising demand for natural, fermented...
Investor Gary Black predicts an initial boost for SpaceX investors following its IPO, driven by expedited inclusion in the Nasdaq-100 and S&P 500 indices and strong underwriter support from Goldman Sachs and Morgan Stanley. However, Black warns that ...
SpaceX is preparing for its IPO with plans to allocate up to 30% of shares to retail investors, a notably large retail offering. Platforms like Robinhood and Sofi allow retail investors to participate without minimum account balances, though they mus...
